Atara Biotherapeutics News

Atara Biotherapeutics | DEFA14A: Others

Apr 26 16:25 ET

Atara Biotherapeutics | DEF 14A: Definitive information statements

Apr 26 16:21 ET

Atara Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:19 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K

Apr 2 18:16 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEIDEN WILLIAM K

Apr 2 18:15 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Roncarolo Maria Grazia

Apr 2 18:15 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Carol Giltner

Apr 2 18:15 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MALLIK AMEET

Apr 2 18:15 ET

Atara Biotherapeutics | 8-K: Current report

Mar 29 16:33 ET

Atara Biotherapeutics | 10-K: Annual report

Mar 28 08:44 ET

Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Mar 28 08:39 ET

Atara Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%), etc.

Mar 18 16:16 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal

Mar 6 18:48 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo

Mar 6 18:48 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar

Mar 6 18:48 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hyllengren Eric J

Mar 6 18:48 ET

Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henrich Jill

Mar 6 18:48 ET

Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 20:21 ET

Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 20:21 ET

Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 20:21 ET